Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01794 (long intergenic non-protein coding RNA 1794) is a gene that encodes a large, autonomously transcribed non-coding RNA situated between protein-coding genes, belonging to the family of long intergenic non-coding RNAs (lincRNAs)[1][3]. LincRNAs are typically over 200 nucleotides in length and serve non-protein-coding, regulatory roles, including the modulation of neighboring gene expression, chromatin structure, and transcriptional activity with tissue specificity[5][9]. While the general lincRNA class is being actively studied and several members have defined roles in development, gene regulation, or disease (notably cancer), as of now, no gene-specific function, associated disease, drug interaction, or biomarker use has been established for LINC01794 specifically in the published literature[1][3][5][9].
Null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1794 (LINC01794).